Autograft vs Allograft

Two sources of tissue for joint repair and reconstruction. Your own tissue versus donor tissue—the trade-offs between healing and harvest.

What an autograft is

An autograft is tissue harvested from one part of your own body and grafted to another part. In orthopedics, the classic example is ACL reconstruction: the surgeon may harvest your hamstring tendon (a small strip from the inner thigh) or your patellar tendon (from the tendon below the kneecap) and use it to rebuild the anterior cruciate ligament. The tissue comes from you, heals reliably because it’s your own biological tissue, and has excellent long-term outcomes.

Why autografts are preferred

The cost of autograft: the harvest site

The downside of autograft is that you have to sacrifice healthy tissue from another site. Taking a hamstring tendon for ACL reconstruction means you lose a small amount of hamstring function (though studies show most people don’t notice). Taking patellar tendon means temporary weakness in knee extension. Some patients experience donor-site pain or weakness that persists for months. This is why choosing the right graft source is important: the surgeon considers the quality of tissue available and the impact on that donor site.

What an allograft is

An allograft is tissue harvested from a deceased donor and processed for transplantation. Tissue banks (regulated by the FDA) screen donors for disease and infection, sterilize the tissue, and store it for when it’s needed. An allograft ACL might come from a donor’s hamstring tendon or patellar tendon, processed and ready to use.

The advantages and disadvantages of allograft

Advantages: No harvest site, meaning you avoid the morbidity of taking tissue from your own body. No donor-site pain, weakness, or loss of function. Faster surgical time because the graft is already available.

Disadvantages: The tissue is not living in the same way as an autograft. It takes longer to revascularize (get new blood supply) and incorporate. The biology is slower and less predictable. There is a small (but real) risk of disease transmission from the donor, despite screening. And there is a theoretical risk of immune rejection, though the graft is usually treated to reduce immunogenicity.

Common sites for grafts and the choice autograft versus allograft

Related pages